Therapeutic vaccine targeted to T cell receptors: Phase I and II Update

Connective Therapeutics Inc. (CNCT), Palo Alto, Calif. Product: Therapeutic vaccine targeted to T cell receptors Indication: Multiple sclerosis Status: CNCT began Phase I/II testing of a T cell recept...